Summit Therapeutics, Inc.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: US86627T1088

USD

18.81

1.56 (9.04%)

Dec 04

NAS

Click here to see other stocks

Summit Therapeutics, Inc. VS Pharmaceuticals & Biotechnology

9.04%

0.3%

5.56%

0.54%

3.24%

-0.03%

YTD

5.41%

16.46%

5.85%

13.22%

2311.54%

68.23%

286.24%

86.81%

10Y

286.24%

234.19%

Stock Absolute Returns
S&P 500Absolute Returns

Price + Dividend

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-20.03%

6 Months

-8.78%

1 Year

5.85%

2 Years

783.1%

3 Years

2311.54%

4 Years

276.2%

5 Years

286.24%

Summit Therapeutics, Inc. for the last several years.

Risk Adjusted Returns v/s S&P 500